Nasal Spray Recalled Due to Contamination With Mold and Bacteria
If you’re using nasal sprays to treat congestion or allergies, you’ll want to check out the latest recall:…
Ozempic Nation – Canadian Affairs
Read: 5 min It took Alexis Adebanke Ladejobi more than a year to try the weight loss drug…
How Ozempic is changing Christmas lunch
Dec 20, 2025 – 5.00am Gift this article Subscribe to gift this article Gift 5 articles to anyone…
Visionary in Biodiversity and Herbal Innovation
The first time I met Palpu Pushpangadan was when he was the director of the National Botanical Research…
Prescription row ignores bitter pill of how we treat our elders
When I worked in a pharmacy during school holidays many years ago, a different policy of dispensing tablets…
The holiday herb with cooling flavors that can ease bloating and soothe muscles
Found in Greek mythology, mint has been a familiar and fresh taste for thousands of years. Just how…
What’s on your mind, Allegra? – J-Wire
Browse > Home / News / What’s on your mind, Allegra? – J-Wire December 19, 2025 by J-Wire…
How FDA’s Lax Generic Drug Rules Can Put Patients’ Lives at Risk — ProPublica
Wrapped in a flashy fur coat she’d found at a thrift store for the occasion, Hannah Goetz blew…
New SSP issued for Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free
In response to a significant ongoing disruption to the supply of Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye…
FDA dings Bristol Myers Squibb, Karuna over TV ad for Cobenfy – MM+M
Bristol Myers Squibb and its subsidiary Karuna Therapeutics received the latest Untitled Letter from the Food and Drug…
US drug prices: Trump announces ‘most favored nation’ deals with nine drug companies
In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals…
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…